Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex EEG Awakening Signs
NCT01161004Phase 4Completed
- Sponsor
- Hôpital Foch
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Hôpital Foch. Started Sep 2010; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01161004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01161004.